Wednesday - December 25, 2024
Mary Ann Liebert: Using Urine NAA Levels to Distinguish Between Mild and Typical Canavan Disease
December 07, 2024
NEW ROCHELLE, New York, Dec. 7 (TNSres) -- Mary Ann Liebert Inc. issued the following news release:

A new study shows that urine levels of N-acetylaspartate (NAA), which accumulates in the urine of patients with the autosomal recessive leukodystrophy Canavan disease, can be used to distinguish between mild and typical forms of the disease. The study is published in the peer-reviewed journal Human Gene Therapy. Click here (https://www.liebertpub.com/doi/10.1089/hum.2024.168) to read . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products